Ultrasound-Guided Three-Level Intercostal Blockade for Tietze Syndrome: Retrospective Analgesic Outcomes


Sarıgül A., Sarıgül N.

International Trakya Family Medicine Congress, Edirne, Türkiye, 16 - 19 Nisan 2026, ss.98-99, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Edirne
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.98-99
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Aim:

Tietze syndrome can impose a clinically meaningful burden

through persistent anterior chest wall pain, tenderness, and

activity limitation, thereby impairing daily functioning and quality

of life. Interventional management of refractory Tietze syndrome

in the literature has largely focused on local costochondral

injections, most commonly combining corticosteroid with local

anesthetic, while ultrasound guidance is increasingly used to

enhance targeting and procedural safety. We aim to evaluated

the mid-term analgesic impact and safety of ultrasound-guided

(USG) three-level intercostal nerve blockade performed as a

targeted regional analgesic strategy.

Method:

We conducted a retrospective, single-center cohort study of

patients treated for clinically diagnosed Tietze syndrome with

USG-guided intercostal blockade. The block was standardized

to the maximally painful intercostal level and the adjacent cranial

and caudal levels (painful level ±1). Under real-time ultrasound

guidance, a bupivacaine–lidocaine local anesthetic mixture was

injected at 3 mL per level (total 9 mL). Pain intensity was

quantified using the visual analog scale (VAS) immediately

before intervention and at the 3rd-month follow-up. Continuous

variables are reported as mean±SD.

Results:

Twenty-three patients were included. Mean pre-procedural VAS

was 7.87±1.42 and decreased to 2.52±2.69 at 3 months,

yielding an absolute mean reduction of 5.35 VAS units. No

procedure-related

complications

or

adverse

events

were

recorded.

Conclusions:

In this retrospective series, USG-guided three-level intercostal

blockade using a bupivacaine–lidocaine mixture was associated

with substantial pain reduction sustained to 3 months and an

excellent safety profile. These data support the feasibility of a

focused ultrasound-guided regional approach for symptomatic

Tietze

syndrome;

prospective

controlled

studies

with

standardized diagnostic criteria and functional endpoints are

needed to define comparative effectiveness and durability